U.S. market Closed. Opens in 6 hours 3 minutes

AZYO | Aziyo Biologics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue49.19M47.39M42.68M42.90M39.04M
Cost of Revenue29.96M28.37M22.12M23.13M23.09M
Gross Profit19.22M19.02M20.56M19.77M15.95M
Operating Expenses45.76M42.05M34.16M28.18M24.17M
Selling, General & Admin36.82M32.79M30.08M25.78M21.68M
Research & Development8.94M9.27M4.08M2.40M2.48M
Other Operating Expenses4.16M3.58M-2.57M1.88M2.20M
Operating Income-26.54M-23.03M-13.60M-8.41M-8.22M
Other Expenses / Income-6.32M-1.75M-8.20M-3.50M2.20M
Before Tax Income-32.86M-24.78M-21.80M-11.91M-11.54M
Income Tax Expenses34.00K55.00K26.00K30.00K26.00K
Net Income-32.90M-24.83M-21.82M-11.94M-11.57M
Interest Expenses5.28M5.32M5.63M5.38M5.52M
Basic Shares Outstanding13.83M10.44M2.85M6.58M6.31M
Diluted Shares Outstanding13.83M10.44M2.85M6.58M6.31M
EBITDA-22.38M-19.45M-16.17M-2.67M-2.20M
EBITDA Margin-45.50%-41.05%-37.88%-6.23%-5.64%
EBIT-27.58M-19.45M-16.17M-6.53M-6.02M
EBIT Margin-56.07%-41.05%-37.88%-15.22%-15.42%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙